USDA funds rural telemedicine efforts

The U.S. Department of Agriculture is investing $23.4 million in 75 projects across 31 states and the Western Pacific to expand distance learning and telemedicine in rural areas.

“Rural communities often lack access to specialized medical care or advanced educational opportunities necessary for stronger rural economies," USDA Secretary Tom Vilsack said in a release. “These grants will help increase access to healthcare and many other essential services.”

The grants are being provided through USDA Rural Development's Distance Learning and Telemedicine program and can be used to purchase equipment to provide educational and telemedicine services to rural communities.

One recipient, the North Slope Borough (Alaska), is receiving a $420,027 grant to purchase video equipment to link six Native Alaskan clinics, four end-user sites and Samuel Simmonds Memorial Hospital. The project will increase access to emergency medical care, examinations and behavioral health and specialized services.

Another recipient, the Baptist Healthcare System in Corbin, Ky., will receive a $182,566 grant to install teleconferencing and telehealth equipment for five facilities in medically underserved areas in rural southeastern Kentucky and east Tennessee.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.